These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7653421)

  • 21. Case of allergic contact dermatitis due to a topical agent containing chlorpheniramine maleate, with a false-negative patch test.
    Ueno T; Kawana S
    J Dermatol; 2008 Jan; 35(1):46-8. PubMed ID: 18181779
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous reactions to chromium.
    Food Cosmet Toxicol; 1973 Jun; 11(3):506-9. PubMed ID: 4580541
    [No Abstract]   [Full Text] [Related]  

  • 23. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact photo-allergy to tribromsalicylanilide.
    Osmundsen PE
    Boll Chim Farm; 1971 Oct; 110(10):590-4. PubMed ID: 5143359
    [No Abstract]   [Full Text] [Related]  

  • 25. Allergy to clobetasol-17-propionate (Dermovate).
    Bachmann-Buffle B
    Dermatologica; 1983; 167(2):104. PubMed ID: 6628801
    [No Abstract]   [Full Text] [Related]  

  • 26. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug-induced contact eczemas and their current causes].
    Kleine-Natrop HE; Richter G
    Allerg Asthma (Leipz); 1969; 15(3):171-82. PubMed ID: 4391902
    [No Abstract]   [Full Text] [Related]  

  • 28. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB; Gold MH; Zib B; Davis MW;
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contact hypersensitivity to topical corticosteroids--frequency of positive reactions in patch-tested patients with allergic contact dermatitis.
    Reduta T; Laudanska H
    Contact Dermatitis; 2005 Feb; 52(2):109-10. PubMed ID: 15725292
    [No Abstract]   [Full Text] [Related]  

  • 30. [Xanthocillin as a local antibiotic and allergen].
    Schubert H
    Allerg Asthma (Leipz); 1969; 15(1):61-6. PubMed ID: 5371335
    [No Abstract]   [Full Text] [Related]  

  • 31. Allergic contact dermatitis due to transdermal buprenorphine.
    Pérez-Pérez L; Cabanillas M; Loureiro M; Fernández-Redondo V; Labandeira J; Toribio J
    Contact Dermatitis; 2008 May; 58(5):310-2. PubMed ID: 18416765
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug disease in medical workers].
    Zherkova EA
    Med Sestra; 1989 Jul; 48(7):45-7. PubMed ID: 2796679
    [No Abstract]   [Full Text] [Related]  

  • 33. Contact sensitivity to clobetasol propionate.
    Spiro JG; Lawrence CM
    Contact Dermatitis; 1986 Feb; 14(2):116-7. PubMed ID: 3709148
    [No Abstract]   [Full Text] [Related]  

  • 34. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
    Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
    J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disulfiram hypersensitivity and rubber contact dermatitis.
    Webb PK; Gibbs SC; Mathias CT; Crain W; Maibach H
    JAMA; 1979 May; 241(19):2061. PubMed ID: 430802
    [No Abstract]   [Full Text] [Related]  

  • 36. Contact dermatitis from estradiol in a transdermal therapeutic system.
    Panhans-Gross A; Gall H; Dziuk M; Peter RU
    Contact Dermatitis; 2000 Dec; 43(6):368-9. PubMed ID: 11140397
    [No Abstract]   [Full Text] [Related]  

  • 37. Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial.
    Vena GA; Cassano N; D'Argento V; Milani M
    Br J Dermatol; 2006 Feb; 154(2):353-6. PubMed ID: 16433809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
    Andres P; Poncet M; Farzaneh S; Soto P
    J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact sensitization to corticosteroids: increased risk in long term dermatoses.
    Corazza M; Mantovani L; Maranini C; Bacilieri S; Virgili A
    Eur J Dermatol; 2000; 10(7):533-5. PubMed ID: 11056424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.